MyWoundDoctor Appoints Donato Tramuto to Board of Directors
NASHVILLE, Tenn.--(BUSINESS WIRE)--MyWoundDoctor, a leader in providing expert wound care management, announced the appointment of Donato Tramuto to its Board...
Month: June 2022
Rushnet, Inc Pursues Spinoff of HeliosDX, Dividend
ALPHARETTA, GA / ACCESSWIRE / June 8, 2022 / RushNet, Inc (OTC PINK:RSHN), (the "Company") is pleased to announce the...
Highmark Interactive Inc. Demonstrates Traction in the US Market Deploying its EQ Remote Physiologic Monitoring Platform with Large, Multi-Site Orthopedic Organization
Highmark announces immediate deployment of its remote physiologic monitoring software across a large 10,000 patient plus multi-clinic orthopedic organization in...
Altamira Therapeutics Reports 89.5% and 98.9% Reduction in Viral Load Against Human Rhinovirus With its Bentrio Nasal Spray
Testing further confirms Bentrio's broad protection against various types of airborne virusesDemonstrates significant reductions in viral load for preventive and...
Halberd Corp. & Mississippi State University Discuss Animal Testing as Prelude to FDA Certification
JACKSON CENTER, PA / ACCESSWIRE / June 8, 2022 / Halberd Corporation (OTC PINK:HALB) and Mississippi State University (MSU) executed...
Gemina Labs Appoints Point-of-Care Diagnostic Executive Brian Firth as Advisor
VANCOUVER, BC / ACCESSWIRE / June 8, 2022 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to...
New Delivery of Dosell to Apoteket AB
STOCKHOLM, SE / ACCESSWIRE / June 8, 2022 / iZafe Group (STO:IZAFE-B)iZafe Group (publ.) hereby announces that a large amount...
Moderna Announces Omicron-Containing Bivalent Booster Candidate mRNA-1273.214 Demonstrates Superior Antibody Response Against Omicron
Data Show Significantly Higher Geometric Mean Titer Ratios, Meeting Prespecified Endpoints for Superiority Against Omicron VariantmRNA-1273.214 Exhibited an 8-Fold Boost...
Zomedica to Present at JMP Securities Life Sciences Conference
ANN ARBOR, MI / ACCESSWIRE / June 8, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health...
SPO Global Inc. Discusses Company’s Medical Devices
Shandong, China, June 08, 2022 (GLOBE NEWSWIRE) -- SPO Global Inc. (OTC PINK: SPOM), a healthcare and biotech company, today...
Optimi Health Finalizes Partnership and Psilocybin Supply Agreement With ATMA Journey Centers
Strategic partnership will focus on improving regulatory outcomes in therapist training and safe supply of psilocybinVANCOUVER, British Columbia, June 08,...
Healthy Extracts New Clinical Study Highlights UBN RELIEF Naturally Alleviates Migraine Symptoms
Double-Blind, Peer-Reviewed Study Presented at 2022 ACSM Annual Meeting Photo 1 UBN RELIEF™ is clinically proven to provide some relief...
CorMedix to Participate at the JMP Securities Life Sciences Conference
BERKELEY HEIGHTS, N.J., June 08, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...
SCYNEXIS Announces Submission of Supplemental New Drug Application of BREXAFEMME® (ibrexafungerp tablets) to the U.S. Food and Drug Administration for an Expanded Indication for the Prevention of Recurrent Vaginal Yeast Infections
Regulatory submission for the label extension is supported by positive data from the pivotal Phase 3 CANDLE study in which...
Allogene Therapeutics Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) Designation to ALLO-501A for Large B Cell Lymphoma
RMAT Designation Follows Positive Data from ALLO-501A ALPHA2 Trial in Heavily Pretreated Patients with Relapsed or Refractory Large B cell...
Evoke Pharma Regains Compliance with Nasdaq Listing Requirements and Provides Financial Update
SOLANA BEACH, Calif., June 08, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily...
WIMI Hologram Academy: The Application of Virtual Reality Technology in Power Grid Fault Monitoring
HONG KONG, June 08, 2022 (GLOBE NEWSWIRE) -- WIMI Hologram Academy, working in partnership with the Holographic Science Innovation Center, has...
Albireo to Present New Data at the EASL International Liver Congress™ 2022
– Five abstracts accepted, long-term data confirmed durable efficacy with Bylvay™ (odevixibat), with demonstrated improvement in quality of life, growth,...
First patient dosed in second Phase 2 add-on Ketamine Trial in Treatment-Resistant Depression (TRD)
Dosing has commenced in HMNC Brain Health and Develco Pharma’s Phase 2 oral prolonged-release Ketamine (KET01) Study The trial will...
Phase III Clinical Study IND Accepted in China for Alimera’s Fluocinolone Acetonide Intravitreal Implant
ATLANTA, June 08, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is...